Comment on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: Results of the GETUG-AFU V05 VESPER trial.
Jian-Jun Ye, Shang-Qing Ren, Yi-Ge Bao
Author Information
- Jian-Jun Ye: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Shang-Qing Ren: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Robotic Minimally Invasive Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, 610072, China.
- Yi-Ge Bao: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: baoyige@hotmail.com.
No abstract text available.
Humans
Cisplatin
Gemcitabine
Methotrexate
Vinblastine
Urinary Bladder Neoplasms
Doxorubicin
Muscles
Cisplatin
Gemcitabine
Methotrexate
Vinblastine
Doxorubicin
